Thermo Fisher Scientific (TMO) Revenue — Quarter Ended Sep 27, 2025
Revenue for the quarter increased compared to both the prior quarter and the same quarter last year. This performance reflects a continuation of the upward trend observed in recent periods.
Key takeaway
Quarter ended Sep 27, 2025 · FY2025 Q3
Revenue for the quarter increased compared to both the prior quarter and the same quarter last year. This performance reflects a continuation of the upward trend observed in recent periods.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$11.1B
Revenue reported for this quarter.
Quarter-over-quarter
+2.5%
Change from the immediately preceding quarter.
Year-over-year
+4.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$43.7B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $11.4B | +4.7% |
| Mar 29, 2025 | $10.4B | +0.2% |
| Jun 28, 2025 | $10.9B | +3.0% |
| Sep 27, 2025 | $11.1B | +4.9% |
Revenue performance
The reported revenue moved higher, marking a sequential gain from the previous quarter. The year-over-year comparison also showed growth.
Quarterly comparison
Compared to the prior quarter, revenue improved; compared to the same quarter a year ago, revenue was also higher. The sequential increase was less pronounced than the year-over-year increase.
What to watch
Cash and cash equivalents declined from the end of the prior fiscal year, while total debt increased, as noted in the liquidity discussion.